Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-24 Purchase | 2022-05-26 6:00 pm | Virpax Pharmaceuticals Inc. | VRPX | Sendrow Jerrold Director | 4,500 | $1.29 | $5,805 | 9,006 (Direct) | View |
| 2022-05-18 Purchase | 2022-05-20 6:15 pm | Virpax Pharmaceuticals Inc. | VRPX | Mack Anthony P. Chief Executive Officer | 75,750 | $1.34 | $101,505 | 2,983,000 (Indirect Direct) | View |
| 2022-05-18 Purchase | 2022-05-20 6:12 pm | Virpax Pharmaceuticals Inc. | VRPX | Floyd Eric Director | 4,479 | $1.3635 | $6,107 | 8,018 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-29 Option Award | 2024-01-31 4:26 pm | N/A 2034-01-28 | Virpax Pharmaceuticals Inc. | VRPX | Singh Vanila Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-01-29 Option Award | 2024-01-31 4:25 pm | N/A 2034-01-28 | Virpax Pharmaceuticals Inc. | VRPX | Shah Vinay Chief Financial Officer | 112,000 | $0 | 112,000 (Direct) | View |
| 2024-01-29 Option Award | 2024-01-31 4:25 pm | N/A 2034-01-28 | Virpax Pharmaceuticals Inc. | VRPX | Jambulingam Thani Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-01-29 Option Award | 2024-01-31 4:24 pm | N/A 2034-01-28 | Virpax Pharmaceuticals Inc. | VRPX | Mathias Sheila Chief Scientific Officer | 112,000 | $0 | 112,000 (Direct) | View |
| 2024-01-29 Option Award | 2024-01-31 4:23 pm | N/A 2034-01-28 | Virpax Pharmaceuticals Inc. | VRPX | Dubin Michael F Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-01-29 Option Award | 2024-01-31 4:23 pm | N/A 2034-01-28 | Virpax Pharmaceuticals Inc. | VRPX | Sendrow Jerrold Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-01-29 Option Award | 2024-01-31 4:22 pm | N/A 2034-01-28 | Virpax Pharmaceuticals Inc. | VRPX | Bruce Gerald W Chief Executive Officer | 125,000 | $0 | 125,000 (Direct) | View |
| 2024-01-29 Option Award | 2024-01-31 4:22 pm | N/A 2034-01-28 | Virpax Pharmaceuticals Inc. | VRPX | Floyd Eric Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2024-01-29 Option Award | 2024-01-31 4:21 pm | N/A 2034-01-28 | Virpax Pharmaceuticals Inc. | VRPX | Ruskin Barbara Director | 25,000 | $0 | 25,000 (Direct) | View |
Ownership | 2023-10-03 09:51 am | 2022-04-07 2031-04-06 | Virpax Pharmaceuticals Inc. | VRPX | Mathias Sheila Chief Scientific Officer | 0 | $0 | 197,676 (Direct) | View |
| 2023-06-20 Option Award(A) | 2023-08-16 5:00 pm | 2024-06-20 2033-06-20 | Virpax Pharmaceuticals Inc. | VRPX | Shah Vinay Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-06-20 Option Award | 2023-06-21 4:18 pm | 2024-06-20 2033-06-20 | Virpax Pharmaceuticals Inc. | VRPX | Shah Vinay Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-04-24 Option Award | 2023-04-26 9:00 pm | 2023-04-24 2033-04-24 | Virpax Pharmaceuticals Inc. | VRPX | Bruce Gerald W Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-03-24 Option Award | 2023-03-28 8:05 pm | 2024-03-24 2033-03-24 | Virpax Pharmaceuticals Inc. | VRPX | Ruskin Barbara Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-01-25 Option Award(A) | 2023-02-07 9:30 pm | N/A 2028-01-25 | Virpax Pharmaceuticals Inc. | VRPX | Mack Anthony P. Chief Executive Officer 10% Owner | 125,000 | $0 | 125,000 (Direct) | View |
| 2023-01-25 Option Award | 2023-01-27 8:30 pm | N/A 2033-01-25 | Virpax Pharmaceuticals Inc. | VRPX | Gudin Jeffrey Chief Medical Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2023-01-25 Option Award | 2023-01-27 8:30 pm | N/A 2033-01-25 | Virpax Pharmaceuticals Inc. | VRPX | Mack Anthony P. Chief Executive Officer 10% Owner | 125,000 | $0 | 125,000 (Direct) | View |
| 2023-01-25 Option Award | 2023-01-27 8:30 pm | N/A 2033-01-25 | Virpax Pharmaceuticals Inc. | VRPX | Chipman Christopher Michael Chief Financial Officer | 112,000 | $0 | 112,000 (Direct) | View |
| 2023-01-01 Option Award | 2023-01-04 8:30 pm | 2024-01-01 2033-01-01 | Virpax Pharmaceuticals Inc. | VRPX | Jambulingam Thani Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-01-01 Option Award | 2023-01-04 8:30 pm | 2024-01-01 2033-01-01 | Virpax Pharmaceuticals Inc. | VRPX | Floyd Eric Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2023-01-01 Option Award | 2023-01-04 8:30 pm | 2024-01-01 2033-01-01 | Virpax Pharmaceuticals Inc. | VRPX | Sendrow Jerrold Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-01-01 Option Award | 2023-01-04 8:30 pm | 2024-01-01 2033-01-01 | Virpax Pharmaceuticals Inc. | VRPX | Dubin Michael F Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-01-01 Option Award | 2023-01-04 8:30 pm | 2024-01-01 2033-01-01 | Virpax Pharmaceuticals Inc. | VRPX | Singh Vanila Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-04-25 Option Award | 2022-04-27 6:00 pm | 2022-04-25 2032-04-25 | Virpax Pharmaceuticals Inc. | VRPX | Bruce Gerald W Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2022-01-31 Option Award(A) | 2022-02-25 4:47 pm | N/A 2032-01-31 | Virpax Pharmaceuticals Inc. | VRPX | Gudin Jeffrey Chief Medical Officer | 60,676 | $0 | 60,676 (Direct) | View |
| 2022-01-31 Option Award(A) | 2022-02-25 4:44 pm | N/A 2032-01-31 | Virpax Pharmaceuticals Inc. | VRPX | Mack Anthony P. Chief Executive Officer 10% Owner | 60,676 | $0 | 60,676 (Direct) | View |
| 2022-01-31 Option Award(A) | 2022-02-25 4:43 pm | N/A 2032-01-31 | Virpax Pharmaceuticals Inc. | VRPX | Chipman Christopher Michael Chief Financial Officer | 60,676 | $0 | 60,676 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 5:02 pm | N/A 2032-01-31 | Virpax Pharmaceuticals Inc. | VRPX | Mack Anthony P. Chief Executive Officer 10% Owner | 150,000 | $0 | 150,000 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 5:01 pm | N/A 2032-01-31 | Virpax Pharmaceuticals Inc. | VRPX | Gudin Jeffrey Chief Medical Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 5:00 pm | N/A 2032-01-31 | Virpax Pharmaceuticals Inc. | VRPX | Chipman Christopher Michael Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-01-01 Option Award | 2022-01-05 5:36 pm | 2023-01-01 2032-01-01 | Virpax Pharmaceuticals Inc. | VRPX | Sendrow Jerrold Director | 12,091 | $0 | 12,091 (Direct) | View |
| 2022-01-01 Option Award | 2022-01-05 5:33 pm | 2023-01-01 2032-01-01 | Virpax Pharmaceuticals Inc. | VRPX | Jambulingam Thani Director | 14,113 | $0 | 14,113 (Direct) | View |
| 2022-01-01 Option Award | 2022-01-05 5:29 pm | 2023-01-01 2032-01-01 | Virpax Pharmaceuticals Inc. | VRPX | Singh Vanila Director | 12,091 | $0 | 12,091 (Direct) | View |
| 2022-01-01 Option Award | 2022-01-05 5:26 pm | 2023-01-01 2032-01-01 | Virpax Pharmaceuticals Inc. | VRPX | Dubin Michael F Director | 12,091 | $0 | 12,091 (Direct) | View |
| 2022-01-01 Option Award | 2022-01-05 5:22 pm | 2023-01-01 2032-01-01 | Virpax Pharmaceuticals Inc. | VRPX | Floyd Eric Director | 15,124 | $0 | 15,124 (Direct) | View |